BIOCARE Trademark

Trademark Overview

On Wednesday, September 10, 2014, a trademark application was filed for BIOCARE with the United States Patent and Trademark Office. The USPTO has given the BIOCARE trademark a serial number of 86391134. The federal status of this trademark filing is REGISTERED AND RENEWED as of Friday, September 5, 2025. This trademark is owned by Blood Systems, Inc.. The BIOCARE trademark is filed in the Advertising, Business and Retail Services and Transportation & Storage Services categories with the following description:

Distribution services, namely, delivery of therapeutic plasma-derivatives and recombinant coagulation products used for hemophilia and thrombophilia treatment, immunology, wound management, and critical care; biopharmaceutical and specialty pharmaceutical distribution services, namely, transport, delivery, packaging and storage of therapeutic plasma-derivatives and recombinant coagulation products for hospitals, clinics, home care companies, hemophilia and thrombosis centers, and physician offices

Consignment inventory services, namely, inventory management in the field of biologic and specialty pharmaceutical products in the nature of therapeutic plasma-derivatives and recombinant coagulation products provided to hospitals, clinics, home care companies, hemophilia and thrombosis centers, and physician offices
biocare

General Information

Serial Number86391134
Word MarkBIOCARE
Filing DateWednesday, September 10, 2014
Status800 - REGISTERED AND RENEWED
Status DateFriday, September 5, 2025
Registration Number4903665
Registration DateTuesday, February 23, 2016
Mark Drawing4 - Illustration: Drawing with word(s) / letter(s) / number(s) in Block form
Published for Opposition DateTuesday, December 8, 2015

Trademark Statements

Goods and ServicesDistribution services, namely, delivery of therapeutic plasma-derivatives and recombinant coagulation products used for hemophilia and thrombophilia treatment, immunology, wound management, and critical care; biopharmaceutical and specialty pharmaceutical distribution services, namely, transport, delivery, packaging and storage of therapeutic plasma-derivatives and recombinant coagulation products for hospitals, clinics, home care companies, hemophilia and thrombosis centers, and physician offices
Pseudo MarkBIO CARE
Goods and ServicesConsignment inventory services, namely, inventory management in the field of biologic and specialty pharmaceutical products in the nature of therapeutic plasma-derivatives and recombinant coagulation products provided to hospitals, clinics, home care companies, hemophilia and thrombosis centers, and physician offices

Classification Information

International Class035 - Advertising; business management; business administration; office functions.
US Class Codes100, 101, 102
Class Status Code6 - Active
Class Status DateThursday, September 18, 2014
Primary Code035
First Use Anywhere DateSaturday, December 31, 1994
First Use In Commerce DateSaturday, December 31, 1994
International Class039 - Transport; packaging and storage of goods; travel arrangement.
US Class Codes100, 105
Class Status Code6 - Active
Class Status DateThursday, March 26, 2015
Primary Code039
First Use Anywhere DateSaturday, December 31, 1994
First Use In Commerce DateSaturday, December 31, 1994

Trademark Owner History

Party NameBIOCARE, INC.
Party Type31 - New Owner After Registration
Legal Entity Type03 - Corporation
AddressTempe, AZ 85282
Party NameBlood Systems, Inc.
Party Type30 - Original Registrant
Legal Entity Type03 - Corporation
AddressScottsdale, AZ 85252
Party NameBlood Systems, Inc.
Party Type20 - Owner at Publication
Legal Entity Type03 - Corporation
AddressScottsdale, AZ 85252
Party NameBlood Systems, Inc.
Party Type10 - Original Applicant
Legal Entity Type03 - Corporation
AddressScottsdale, AZ 85252

Trademark Events

Event DateEvent Description
Saturday, September 13, 2014NEW APPLICATION ENTERED
Thursday, September 18, 2014NEW APPLICATION OFFICE SUPPLIED DATA ENTERED
Friday, September 19, 2014NOTICE OF PSEUDO MARK E-MAILED
Sunday, December 21, 2014ASSIGNED TO EXAMINER
Sunday, December 21, 2014NON-FINAL ACTION E-MAILED
Sunday, December 21, 2014NON-FINAL ACTION WRITTEN
Sunday, December 21, 2014NOTIFICATION OF NON-FINAL ACTION E-MAILED
Wednesday, March 25, 2015TEAS RESPONSE TO OFFICE ACTION RECEIVED
Thursday, May 21, 2015ASSIGNED TO EXAMINER
Friday, September 18, 2015EXAMINERS AMENDMENT -WRITTEN
Friday, September 18, 2015EXAMINERS AMENDMENT E-MAILED
Friday, September 18, 2015NOTIFICATION OF EXAMINERS AMENDMENT E-MAILED
Friday, September 18, 2015EXAMINER'S AMENDMENT ENTERED
Tuesday, September 22, 2015APPROVED FOR PUB - PRINCIPAL REGISTER
Wednesday, March 25, 2015CORRESPONDENCE RECEIVED IN LAW OFFICE
Thursday, March 26, 2015TEAS/EMAIL CORRESPONDENCE ENTERED
Tuesday, April 21, 2015FINAL REFUSAL WRITTEN
Tuesday, April 21, 2015FINAL REFUSAL E-MAILED
Tuesday, April 21, 2015NOTIFICATION OF FINAL REFUSAL EMAILED
Monday, November 2, 2015LAW OFFICE PUBLICATION REVIEW COMPLETED
Tuesday, February 23, 2016REGISTERED-PRINCIPAL REGISTER
Wednesday, January 17, 2018AUTOMATIC UPDATE OF ASSIGNMENT OF OWNERSHIP
Tuesday, June 11, 2019TEAS REVOKE/APP/CHANGE ADDR OF ATTY/DOM REP RECEIVED
Wednesday, October 28, 2015ASSIGNED TO LIE
Wednesday, November 18, 2015NOTIFICATION OF NOTICE OF PUBLICATION E-MAILED
Tuesday, December 8, 2015PUBLISHED FOR OPPOSITION
Tuesday, December 8, 2015OFFICIAL GAZETTE PUBLICATION CONFIRMATION E-MAILED
Tuesday, June 11, 2019ATTORNEY/DOM.REP.REVOKED AND/OR APPOINTED
Wednesday, June 22, 2022CASE ASSIGNED TO POST REGISTRATION PARALEGAL
Thursday, September 29, 2022NOTICE OF ACCEPTANCE OF SEC. 8 & 15 - E-MAILED
Sunday, February 23, 2025COURTESY REMINDER - SEC. 8 (10-YR)/SEC. 9 E-MAILED
Tuesday, February 23, 2021COURTESY REMINDER - SEC. 8 (6-YR) E-MAILED
Wednesday, January 19, 2022TEAS SECTION 8 & 15 RECEIVED
Thursday, June 23, 2022POST REGISTRATION ACTION MAILED - SEC. 8 & 15
Wednesday, September 28, 2022TEAS RESPONSE TO OFFICE ACTION-POST REG RECEIVED
Thursday, September 29, 2022REGISTERED - SEC. 8 (6-YR) ACCEPTED & SEC. 15 ACK.
Friday, May 2, 2025TEAS SECTION 8 & 9 RECEIVED
Friday, September 5, 2025CASE ASSIGNED TO POST REGISTRATION PARALEGAL
Friday, September 5, 2025REGISTERED - SEC. 8 (10-YR) ACCEPTED/SEC. 9 GRANTED
Friday, September 5, 2025REGISTERED AND RENEWED (FIRST RENEWAL - 10 YRS)
Friday, September 5, 2025NOTICE OF ACCEPTANCE OF SEC. 8 & 9 - E-MAILED

Related Keywords

biocare products recombinant coagulation derivatives hemophilia care services plasma namely therapeutic